David Johnson, president and CEO of BioCrossroads, the states initiative to develop the life sciences, said hes not aware of any other university using ITRACs approach to translate discovery into action.
Its revolutionary, Johnson said. Although its in an academic environment, ITRAC tries to bridge the gap between the traditional the pure discovery domain of academic research and the very applied discovery domain of corporate research and development. Its an approach that says were going to borrow some of the project management processes that organize corporate research and focus more specifically on outcomes.
Leaders at the IU Simon Cancer Center approached BioCrossroads for insights into project management practices used in the corporate world.
In addition to grant money, ITRAC helps researchers map out their projects, and it provides expertise to scientists who have made significant discoveries in their labs but arent sure what steps are necessary to turn those discoveries into products that will improve patient care. This decreases the amount of time the scientists have to spend running around trying to find out how to accomplish the next step in their projects.
The program complements a growing emphasis by the National Institutes of Health on accelerating the development and testing processes that basic science laboratory discoveries go through to become new patient treatments. One of the major goals of National Cancer Institute designated centers like the IU Simon Cancer Center is to increase translational initiatives.
IU Simon Cancer Center committees review research projects and identify those with the most potential for clinical applications as well as commercial potential potential that the individual scientists may not even realize is there.
Since its establishment in Nove
'/>"/>
| Contact: Cindy Fox Aisen caisen@iupui.edu 317-274-7722 Indiana University Source:Eurekalert |